Index
- ACS Infectious Diseases Journal
- apprenticeship training
- commercialising medtech
- Compressors
- CSIRO
- IBSA Group
- Indian Institute of Science (IISc)
- Industry 5.0
- IoT
- Johnson & Johnson Innovation LLC
- Johnson & Johnson Innovation Partnering Office
- low-latency communication
- Manufacturing and Engineering Industry Reference Committee
- monash university
- Mynvax
- novel healthcare solutions
- pharmaceuticals
- preventative maintenance plan
- remote commercial applications
- Sullair
- Tactile Internet
- University of Sydney
- Victorian government
- “warm” COVID-19 vaccine
-
Critical manufacturing trades qualifications are being updated
July 20, 2021 0 comment
Manufacturing and Engineering Industry Reference Committee chair, Kristian Stratton, speaks with Manufacturers’ Monthly about the latest skills for apprenticeship training to meet industry needs.
-
The benefits of a preventative maintenance plan
July 20, 2021 0 comment
Sullair Australia’s Shael Esler explains the importance of having a preventative maintenance plan and how transformative it can be for a business.
-
Tactile Internet being developed at the University of Sydney
July 20, 2021 0 comment
A postdoctoral research associate at the University of Sydney’s Centre for IoT and Telecommunications, Dr Zhanwei Hou, is developing a communication method called Tactile Internet – a technology that will allow users to experience touch over the internet.
-
“Warm” COVID-19 vaccine effective against all variants, CSIRO says
July 20, 2021 0 comment
Researchers from the CSIRO, Australia’s national science agency, have evaluated a “warm” COVID-19 vaccine suitable for remote and resource-limited locations that lack access to cold storage supply chains.
-
Johnson & Johnson Innovation Partnering Office produces more health solutions
July 16, 2021 0 comment
The Johnson & Johnson Innovation Partnering Office collaboration – established by Monash University, Johnson & Johnson Innovation LLC and the Victorian government – has been extended. This will mean more novel healthcare solutions will be developed for commercialisation.